Horizon Blue Cross Blue Shield of New Jersey said Tuesday it won't renew any of its 2013 policies for individuals and small-business owners after the end of the year because it would be next to impossible to undo the work it has put in preparing for Obamacare.
Turns out, if you like your old policy, you can’t keep it, after all.
Horizon Blue Cross Blue Shield of New Jersey said Tuesday it won’t renew any of its 2013 policies for individuals and small-business owners after the end of the year because it would be next to impossible to undo the work it has put in preparing for Obamacare.
The decision by the state’s biggest health insurer means its customers will face sharply higher premiums, provided they make too much money to qualify for a federal tax break.
“It hurts,” said Anthony Falcone, 52, of Middletown. “It’s $400 more than I’m paying now. A month.”
Read the full story here: http://on.app.com/1hMuD6o
Source: Asbury Park Press
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More